Last reviewed · How we verify

NCT03043716: TelePAP

Long-term Observation of PAP-therapy With Telemonitoring: Telemedicine Registry TelePAP

Active, enrolled Last updated 28 May 2024
What this trial tests

trial testing PAP therapy with telemonitoring in Obstructive Sleep Apnea in 14,147 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 August 2017
Primary endpoint
30 September 2025
31 December 2025

Quick facts

Lead sponsorResMed
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment14,147
Start date1 August 2017
Primary completion30 September 2025
Estimated completion31 December 2025
Sites6 locations across Germany

Drugs / interventions tested

Conditions studied

Sponsor

ResMed — full company profile →

Who can join

Adults 18 to 99, any sex, with Obstructive Sleep Apnea or Central Sleep Apnea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Telemonitoring for Positive Airway Pressure (PAP) therapy might help to establish and maintain long-term therapy adherence and thus support the beneficial effects of PAP therapy on long-term outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of PAP therapy with telemonitoring

Trials testing the same drug.

Other recruiting trials for Obstructive Sleep Apnea

Currently open trials in the same condition.

Other ResMed trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03043716.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing